The Wyss Center has earned CE mark certification for its NeuroKey brain-computer interface (BCI), a neural signal processing software platform that works with implantable devices.

The software decodes neural signals acquired from implanted electrodes in the patient’s brain and runs an auditory feedback speller that prompts the user to select letters to form words and sentences.

The NeuroKey BCI software is currently being used in a single case home-based study to enable communication for a patient with amyotrophic lateral sclerosis. The platform includes a simple graphical interface that makes it easy for family or caregivers to launch and calibrate the BCI system.